Type 1 Diabetes Mellitus Clinical Trials in San Francisco, California

5 studies are recruiting for type 1 diabetes mellitus in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Type 1 Diabetes Extension Study

   This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long…

   Stage

   Not phased

   Ages

   8 to 35

   Site

   UCSF School of Medicine, San Francisco, California

   Locations

   12 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT02734277 on ClinicalTrials.gov

2. A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

   This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenou…

   Stage

   Phase 3

   Ages

   1 to 25

   Site

   University of California San Francisco - Mission Bay- Site Number : 8400011, San Francisco, California

   Locations

   197 in total

   Run by

   Sanofi

   See if you can join NCT07088068 on ClinicalTrials.gov

3. Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

   This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (within 100 days of diagnosis). Participants will be administered rezpegaldesleukin/placebo once eve…

   Stage

   Phase 2

   Ages

   8 to 45

   Site

   University of California San Francisco, San Francisco, California

   Locations

   15 in total

   Run by

   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

   See if you can join NCT07142252 on ClinicalTrials.gov

4. INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

   INHALE-1st is a Phase 2, single-arm, multi-center, clinical study evaluating the safety and efficacy of Afrezza in combination with subcutaneously-injected basal insulin (BI) for youth 6 to <18 years old with newly diagnosed stage 3 type 1 diabetes (T1D). The study will also evaluate the effect of …

   Stage

   Phase 2

   Ages

   6 to 17

   Site

   University of California San Francisco, San Francisco, California

   Locations

   10 in total

   Run by

   Mannkind Corporation

   See if you can join NCT07224321 on ClinicalTrials.gov

5. A Study of GNTI-122 in Adults Recently Diagnosed With T1D

   This is a 78-week single arm, multi-center, Phase 1 study to evaluate the safety, tolerability, cellular kinetics, and biomarker changes in C-peptide over time of GNTI-122, an investigational cell therapy manufactured from a participant's own blood cells in adult participants with recently diagnose…

   Stage

   Phase 1

   Ages

   18 to 55

   Site

   University of California - San Francisco, San Francisco, California

   Locations

   10 in total

   Run by

   GentiBio, Inc

   See if you can join NCT06919354 on ClinicalTrials.gov